![Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-019-0267-8/MediaObjects/41408_2019_267_Fig1_HTML.png)
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
![Effect of specimen type on free immunoglobulin light chains analysis on the Roche Diagnostics cobas 8000 analyzer | SpringerPlus | Full Text Effect of specimen type on free immunoglobulin light chains analysis on the Roche Diagnostics cobas 8000 analyzer | SpringerPlus | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40064-015-1546-x/MediaObjects/40064_2015_1546_Fig2_HTML.gif)
Effect of specimen type on free immunoglobulin light chains analysis on the Roche Diagnostics cobas 8000 analyzer | SpringerPlus | Full Text
![A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S](https://journals.sagepub.com/cms/10.1177/0004563212473447/asset/images/large/10.1177_0004563212473447-fig1.jpeg)
A multicentre study comparing two methods for serum free light chain analysis - RJ Lock, R Saleem, EG Roberts, MJ Wallage, TJ Pesce, A Rowbottom, SJ Cooper, ED McEvoy, JL Taylor, S
![Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-019-0267-8/MediaObjects/41408_2019_267_Fig3_HTML.png)
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
![A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay](https://www.oatext.com/img/HMO-4-195-g003.gif)
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
![In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00751-0/MediaObjects/41408_2022_751_Fig1_HTML.png)
In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal
![Neurolife disponibiliza Freelite® Mx para diagnóstico da esclerose múltipla – Neurolife Análise do Líquor Neurolife disponibiliza Freelite® Mx para diagnóstico da esclerose múltipla – Neurolife Análise do Líquor](https://neurolife.com.br/wp-content/uploads/2021/01/esclerose-multipla-freelite-kit-diagnostico-kappa-lambda.png)
Neurolife disponibiliza Freelite® Mx para diagnóstico da esclerose múltipla – Neurolife Análise do Líquor
![Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S151684841500170X-gr1.jpg)
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
![Kappa and lambda distribution scatter diagram for A, N Latex FLC assays... | Download Scientific Diagram Kappa and lambda distribution scatter diagram for A, N Latex FLC assays... | Download Scientific Diagram](https://www.researchgate.net/publication/330903160/figure/fig1/AS:11431281180497189@1691617941436/Kappa-and-lambda-distribution-scatter-diagram-for-A-N-Latex-FLC-assays-and-B-Freelite.png)
Kappa and lambda distribution scatter diagram for A, N Latex FLC assays... | Download Scientific Diagram
![Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis | Semantic Scholar Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b599f8a40f47cbd78b0733e7c1190c58cc49f39a/4-Figure2-1.png)
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis | Semantic Scholar
Freelite® Human Kappa Free kit For use on the Roche Cobas Integra® For in vitro diagnostic use Product Code: LK016.RI
![A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay](https://www.oatext.com/img/HMO-4-195-g001.gif)
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
![Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/10154338-ee7f-4b52-aec0-62fdf281e1c4/hsr2113-fig-0002-m.jpg)
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
![Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer](https://www.degruyter.com/document/doi/10.1515/cclm-2021-1029/asset/graphic/j_cclm-2021-1029_fig_001.jpg)